Our results suggest that the calpain-calpastatin system could be involved in a wide variety of demyelinating diseases in the PNS, such as CMT1E, the demyelinating form of Guillain-Barré syndrome, and neuropathic pain, among others. The gene discussed is CAST; the disease is Guillain-Barre syndrome.